Department of Urology, University Hospital Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, 01307 Dresden, Germany.
Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):329-38. doi: 10.1007/s00210-010-0493-x. Epub 2010 Feb 25.
The muscarinic receptor antagonist propiverine used for therapy of overactive bladder undergoes first pass metabolism, leading to several active metabolites, which affect muscarinic receptors and L-type Ca(2+) channels with different potencies. M-5, the major metabolite in blood, and M-6 can be synthesized as cis- and trans-isomers. We systematically investigated the pharmacodynamic profiles of the isomers on detrusor contractile function. In murine and porcine detrusor, the effects of the derivatives were examined on contractions induced by electric field stimulation (EFS), cumulatively increasing concentrations of carbachol or high KCl concentration. EFS contractions were concentration-dependently reduced by the M-5 and M-6 isomers although to a different extent. M-5(cis) was slightly more potent than M-5(trans), but the differences did not reach statistical significance. M-6(cis) was significantly more potent than M-6(trans). Responses to carbachol were antagonized by all compounds due to rightward shifts of the concentration-response curves, but only M-5(trans) also significantly reduced the maximum response. pK (B) values obtained with Schild plot analysis indicated slightly higher potency for M-6(cis) than M-6(trans). Ca(2+) influx-dependent contractions elicited by K(+) depolarization were less impaired by low concentrations of the M-6 isomers, but strongly suppressed by 100 microM of the M-5 isomers, suggesting an additional effect of the two M-5 isomers on Ca(2+) influx. All investigated isomers of M-5 and M-6 are biologically active in reducing detrusor contraction in animal tissue. While M-5( cis,) M-6(cis), and M-6(trans) possess surmountable or partially surmountable antagonistic properties at muscarinic receptors, M-5(trans) is a strong non-competitive antagonist. However, at higher concentration ranges, all four compounds seem to have additional effects on Ca(2+) influx.
用于治疗膀胱过度活动症的毒蕈碱受体拮抗剂丙哌维林经历首过代谢,产生几种具有不同效力的活性代谢物,这些代谢物影响毒蕈碱受体和 L 型钙 (Ca(2+)) 通道。在血液中,主要的代谢物 M-5 和 M-6 可以合成顺式和反式异构体。我们系统地研究了异构体对逼尿肌收缩功能的药效学特征。在小鼠和猪的逼尿肌中,通过电刺激 (EFS) 诱导的收缩、累积增加的乙酰胆碱或高 KCl 浓度来检测衍生物的作用。尽管程度不同,但 M-5 和 M-6 异构体浓度依赖性地降低 EFS 引起的收缩。M-5(cis) 比 M-5(trans) 略有效,但差异无统计学意义。M-6(cis) 比 M-6(trans) 更有效。由于浓度-反应曲线右移,所有化合物均拮抗了对乙酰胆碱的反应,但只有 M-5(trans) 还显著降低了最大反应。Schild 作图分析得到的 pK (B) 值表明,M-6(cis) 的效力略高于 M-6(trans)。低浓度的 M-6 异构体对由 K(+) 去极化引起的 Ca(2+) 内流依赖性收缩的影响较小,但 100 μM 的 M-5 异构体强烈抑制,表明这两种 M-5 异构体对 Ca(2+) 内流有额外作用。在动物组织中,所有研究的 M-5 和 M-6 异构体都具有降低逼尿肌收缩的生物学活性。虽然 M-5(cis)、M-6(cis) 和 M-6(trans) 在毒蕈碱受体上具有可跨越或部分可跨越的拮抗特性,但 M-5(trans) 是一种强非竞争性拮抗剂。然而,在较高的浓度范围内,所有四种化合物似乎对 Ca(2+) 内流有额外的作用。